Check out the FULL program for the 27th Annual Meeting, May 7-11, online or print the PDF!
Pompe disease occurs when the genes that instruct our cells to create the GAA enzyme are faulty. The GAA enzyme’s job is to break down complex molecules like glycogen, which is a substance that helps our body store energy.
The American Society of Gene & Cell Therapy (ASGCT) released its latest resource profiling disease-specific treatment efforts, this time focusing on developing gene therapies for Pompe disease.
Watch ASGCT's Pompe Disease and Gene Therapy Video
The resources on Pompe disease are now available on ASGCT.org. Pompe disease is a genetic disorder that occurs when our bodies lack an important digestive enzyme called acid alpha-glucosidase, or GAA for short. You can learn more about the effect of Pompe disease on the body here.
The information on Pompe disease is part of the launch of a second round of material in ASGCT’s Patient Education program. ASGCT has been releasing new resources weekly on the Patient Education portal. Check out what we have released so far, and keep an eye on our website for the last new resource of 2019—CAR T Basics—on December 3.
Let us know what you think of this second batch of resources. Send feedback via the ASGCT Contact form or at info@asgct.org.
May 7-11, 2024 | Baltimore, MD
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico